Table 2 The clinical relevance of CDO1 expression in patients with GC.
Characteristics | CDO1 | χ2-Value | P-value | |
---|---|---|---|---|
Low expression | High expression | |||
Gender | ||||
Male | 67 | 28 | 2.0701 | 0.1503 |
Female | 20 | 15 | ||
Age | ||||
<60 | 41 | 26 | 2.050 | 0.1522 |
≥60 | 46 | 17 | ||
Tumor size | ||||
<6 | 25 | 24 | 8.9841 | 0.0027 |
≥6 | 62 | 19 | ||
pT stage | ||||
pT2 | 7 | 1 | 3.5902 | 0.1661 |
pT3 | 4 | 5 | ||
pT4 | 76 | 37 | ||
pN stage | ||||
pN0 | 18 | 11 | 0.3973 | 0.5285 |
pN1-3 | 69 | 32 | ||
Tumor location | ||||
Upper third | 6 | 10 | 4.4800 | 0.3450 |
Midle third | 9 | 6 | ||
Lower third | 10 | 7 | ||
More than2/3third All | 5 | 2 | ||
Lauren type | ||||
Intestinal | 67 | 29 | 3.7072 | 0.1567 |
Diffuse | 29 | 11 | ||
Mixed | 1 | 3 |